MYRIS THERAPEUTICS
LIVE

Serial Number

99032070

Owner

Myris Therapeutics Inc.

Attorney

Michael E. Dukes

Filing Date

Feb 6, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MYRIS THERAPEUTICS Trademark

Serial Number: 99032070

MYRIS THERAPEUTICS is a trademark filed by Myris Therapeutics Inc. on February 6, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Myris Therapeutics Inc. (3 trademarks)

307 23rd St Ext
Sharpsburg, PA 15275

Entity Type: 03

Trademark Details

Filing Date

February 6, 2025

Registration Date

Not Registered

Published for Opposition

March 10, 2026

Goods & Services

Biotechnology research; Medical research; Pharmaceutical research and development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 22, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 22, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 23, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 6, 2025 MAFR
NEW APPLICATION ENTERED
Feb 6, 2025 NWAP